Murali Krishna Addepalli,Deborah H. Charych,Seema Kantak,Steven Robert Lee
申请号：
US15120214
公开号：
US10010587B2
申请日:
2015.02.20
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The invention relates to (among other things) method of administering to a patient suffering from a cancer, the method comprising the steps of: (a) an IL-2Rβ-activating amount of a long acting, IL-2Rβ-selective agonist； and (b) a CTLA-4 pathway-inhibiting amount of an anti-CTLA-4 antibody or a PD-1 pathway-inhibiting amount of an anti-PD-1 antibody.
